NEWS Proscere Bioscience $200M Revenue Projection CBD Coldwater Extraction Moves Forward
San Francisco, California, May 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), announces today that the company has completed its testing and will move forward with Proscere Bioscience’s CBD coldwater extraction systems and initial $20M in orders.
Under COVID19 rules, the company audit for the year ending 12/31/2019 is completed and scheduled for filing, and the quarter ending 3/31/2020 will follow shortly.
Richard Hylen, CEO, stated, “The Company has endured the COVID19, and can proceed forward in 2 weeks in completing CBD coldwater extraction purchase orders. We have new interest from commercial players in the CBD industry who is now seeking quotes. Proscere Bioscience will spearhead the revenue for our company. Our subsidiaries, Satel and our Simlatus broadcast systems, continue to produce revenue as a part of our diversification. All of our companies show extreme promise in growing revenues this year.”
The company operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry. Proscere Bioscience manufactures the first commercial industry standard cold-water CBD extraction system for medical grade cannabis utilization, along with their aeroponic commercial grade technology control containers for government food-safety programs, commercial and medical grade CBD. Satel Group is the premier high-rise DirecTV providers in the San Francisco metropolitan area, and is now expanding both DirecTV and Internet services across the SF Bay Area. Simlatus manufactures its own proprietary systems for the major broadcast studios, such as Warner Bros., Fox News, CBS and DirecTV. Its video technology is the major system used for underwater oil exploration in the world.
.02 + HERE WE COME!!! GET READY FOR THE BOOM!
